- Home
- KROS vs ROIC Comparison
KROS vs ROIC Comparison
Compare KROS & ROIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- ROIC
- Stock Information
- Founded
- KROS 2015
- ROIC 2007
- Country
- KROS United States
- ROIC United States
- Employees
- KROS N/A
- ROIC N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- ROIC Real Estate Investment Trusts
- Sector
- KROS Health Care
- ROIC Real Estate
- Exchange
- KROS Nasdaq
- ROIC Nasdaq
- Market Cap
- KROS 1.8B
- ROIC 2.0B
- IPO Year
- KROS 2020
- ROIC N/A
- Fundamental
- Price
- KROS $56.62
- ROIC $17.35
- Analyst Decision
- KROS Strong Buy
- ROIC Hold
- Analyst Count
- KROS 8
- ROIC 6
- Target Price
- KROS $91.43
- ROIC $15.75
- AVG Volume (30 Days)
- KROS 383.1K
- ROIC 3.7M
- Earning Date
- KROS 11-06-2024
- ROIC 10-22-2024
- Dividend Yield
- KROS N/A
- ROIC 3.46%
- EPS Growth
- KROS N/A
- ROIC 57.91
- EPS
- KROS N/A
- ROIC 0.46
- Revenue
- KROS $651,000.00
- ROIC $336,785,000.00
- Revenue This Year
- KROS $1,232.45
- ROIC N/A
- Revenue Next Year
- KROS $126.39
- ROIC $1.15
- P/E Ratio
- KROS N/A
- ROIC $37.83
- Revenue Growth
- KROS 8037.50
- ROIC 4.18
- 52 Week Low
- KROS $27.31
- ROIC $11.87
- 52 Week High
- KROS $73.00
- ROIC $17.40
- Technical
- Relative Strength Index (RSI)
- KROS 38.94
- ROIC 72.76
- Support Level
- KROS $65.54
- ROIC $16.41
- Resistance Level
- KROS $70.26
- ROIC $17.39
- Average True Range (ATR)
- KROS 3.17
- ROIC 0.24
- MACD
- KROS -0.64
- ROIC 0.09
- Stochastic Oscillator
- KROS 9.07
- ROIC 97.81
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About ROIC Retail Opportunity Investments Corp. (MD)
Retail Opportunity Investments Corp is a self-managed real estate investment trust. The company specializes in the acquisition, ownership and management of necessity-based community and neighborhood shopping centers on the west coast of the United States, anchored by supermarkets and drugstores. The Company's primary business is the ownership, management, and redevelopment of retail real estate properties.